4.5 Article

The Epidemiology of Psoriatic Arthritis Over Five Decades: A Population-Based Study

期刊

ARTHRITIS & RHEUMATOLOGY
卷 73, 期 10, 页码 1878-1885

出版社

WILEY
DOI: 10.1002/art.41741

关键词

-

资金

  1. Rochester Epidemiology Project of the National Institute on Aging, NIH [R01-AG-034676]
  2. National Center for Advancing Translational Sciences, NIH [UL1-TR-002377]
  3. National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH [T32-AR-56950]
  4. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
  5. CDC, a Rheumatology Research Foundation Scientist Development award
  6. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery
  7. Eaton Family Career Development award
  8. Women's Health Career Enhancement award

向作者/读者索取更多资源

The study found that the incidence of PsA in a predominantly White US population was stable from 2000 to 2017, in contrast to previous years. However, an increasing proportion of women with PsA was found in this study.
Objective To determine the incidence of psoriatic arthritis (PsA) in a US population and describe trends in incidence and mortality over 5 decades. Methods The previously identified population-based cohort that included Olmsted County, Minnesota residents >= 18 years of age who fulfilled PsA criteria during 1970-1999 was extended to include patients with incident PsA during 2000-2017. Age- and sex-specific incidence rates and point prevalence, adjusted to the 2010 US White population, were reported. Results There were 164 incident cases of PsA in 2000-2017 (mean +/- SD age 46.4 +/- 12.0 years; 47% female). The overall age- and sex-adjusted annual incidence of PsA per 100,000 population was 8.5 (95% confidence interval [95% CI] 7.2-9.8) and was higher in men (9.3 [95% CI 7.4-11.3]) than women (7.7 [95% CI 5.9-9.4]) in 2000-2017. Overall incidence was highest in the 40-59 years age group. The incidence rate was relatively stable during 2000-2017, with no evidence of an overall increase or an increase in men only (but a modest increase of 3% per year in women), compared to 1970-1999 when a 4%-per-year increase in incidence was observed. Point prevalence was 181.8 per 100,000 population (95% CI 156.5-207.1) in 2015. The percentage of women among those with PsA increased from 39% in 1970-1999 and 41% in 2000-2009 to 54% in 2010-2017 (P = 0.08). Overall survival in PsA did not differ from the general population (standardized mortality ratio 0.85 [95% CI 0.61-1.15]). Conclusion The incidence of PsA in this predominantly White US population was stable in 2000-2017, in contrast to previous years. However, an increasing proportion of women with PsA was found in this study.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据